IBS and The Gut Microbiome

If you experience bloating, abdominal pain, unpredictable bowel movements, or that nagging discomfort after meals, you’re not alone. Around 10–15% of people globally live with Irritable Bowel Syndrome (IBS). And while the condition has confused doctors and patients alike, science is starting to shed light on a key player: your gut microbiome.

What Is IBS?

IBS is a functional gastrointestinal disorder that affects how the gut behaves, not its structure. It’s often associated with abdominal pain, altered bowel habits (diarrhoea, constipation, or both), and a significant impact on quality of life. There’s no single known cause, but recent studies suggest one of the most important pieces of the puzzle may lie in the gut’s microbial community.

Your Gut Microbiome: The Hidden World Within

Your intestines are home to trillions of bacteria, viruses, fungi, and other microorganisms. This ecosystem, known as the gut microbiome, helps digest food, regulate the immune system, and even influence brain function. When balanced, the microbiome can promote gut health. When disrupted, a state known as dysbiosis may contribute to symptoms of IBS.

How Is the Microbiome Involved in IBS?

• Lower Microbial Diversity: Research has shown that individuals with IBS often have a less diverse range of gut bacteria compared to those without the condition.
• Inflammatory Microbial Patterns: Some studies have noted increased levels of bacteria linked to gut inflammation and decreased populations of beneficial species, like Bifidobacteria and Faecalibacterium prausnitzii.
• Gas Production and Fermentation: Certain microbes in the gut ferment food in a way that produces gas and short-chain fatty acids. In people with IBS, this process may be exaggerated, leading to bloating and discomfort.
• Gut-Brain Signalling: The microbiome interacts with the nervous system via the gut-brain axis, which may help explain why IBS is so closely linked to mood disorders like anxiety and depression.

Exploring Microbiome-Targeted Therapies

Probiotics are live microorganisms, typically specific strains of bacteria or yeast that may confer a health benefit when consumed in adequate amounts. Some studies suggest that probiotics can help regulate bowel movements, reduce bloating, and ease abdominal discomfort in IBS. Benefits appear to be strain-specific, and the effects can vary depending on the subtype of IBS (constipation-predominant, diarrhea-predominant, or mixed). For example:

• Bifidobacterium infantis 35624 has shown promise in reducing abdominal pain and bloating.
• Lactobacillus plantarum strains may improve stool frequency and consistency.

While probiotics are generally safe, responses are highly individual, and choosing a clinically tested strain is important. Over-the-counter products may vary widely in quality and content.

Prebiotics are non-digestible fibres that selectively feed beneficial gut bacteria. Examples include inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS).

In theory, prebiotics help encourage a more balanced microbiome by stimulating the growth of helpful species like Bifidobacteria. However, in people with IBS, especially those who are sensitive to fermentable fibres (FODMAPs). Some patients tolerate low doses or may benefit from specific formulations, but this is best done with professional guidance, especially during a low-FODMAP diet reintroduction phase.

Diet remains one of the most powerful tools for influencing the gut microbiome and managing IBS symptoms. Among the most studied dietary strategies:

• Low-FODMAP diet: This evidence-backed approach restricts fermentable carbohydrates that are poorly absorbed in the small intestine and rapidly fermented by gut bacteria. It has shown consistent benefits in reducing symptoms, particularly bloating, gas, and abdominal pain.
• Fibre modification: Soluble fibres (like psyllium) can improve symptoms in IBS-C (constipation-predominant), while insoluble fibres may aggravate symptoms in some people.

Long-term use of restrictive diets can potentially reduce microbial diversity, so it’s important to reintroduce tolerated foods gradually with the support of a qualified practitioner.

The field of microbiome targeted therapies is evolving rapidly, but there is no one-size-fits-all solution, especially for IBS. What works for one person may not work for another. The best outcomes often come from a combination of strategies: a well-balanced diet, stress management, and working closely with a qualified professional to develop an individualised approach.